Aetna Inc. (NYSE:AET) closed its last session at $117.00 with the change of +1.33%. The market capitalization of the company is $41.02B with an average Volume of 2.52 million shares. The stock currently has its 52-Week High range of $125.47 and 52-week low range of $92.42. The Price to Book (P/B) ratio stands at 2.41. The stock traded total quantity of 6.43 million shares.
For the current Fiscal Quarter, 19 analysts have given an average earnings per share forecast of $2.12. The Low Earnings per share estimate of the current Quarter is $2 and High Estimate is set at $2.23 according to these Analysts opinions. The Previous Year EPS of this Quarter is $2.05.
According to 16 analysts, an average sales Estimate of the current Fiscal quarter is $15.69B. The lower sales estimate is $15.16B and higher sales estimate is $16.14B according to these Analysts thoughts.
The Company currently has Highest Price Target of $163 and Lowest Price Target of $118. It has Median Price Targets of $140.5. Mean price target is set at $139.75 after consensus analysis of 16 brokers.
When having look at Recommendation Trends of the analysts polled at Thomson First call, for the Current month 6 analysts have assigned this stock as Strong Buy where 10 assigned Buy, 6 analysts believe it’s a Hold, 0 said Underperform and 0 assigned Sell rating.
Halozyme Therapeutics, Inc. (NASDAQ:HALO) ended its last trade at $9.11 The company has market value of $1.16B with the total traded volume of 1.38 million. The stock currently has its 52-Week top value of $25.25 and 52-week down value of $6.96. The price to book (P/B) ratio of the company is 39.44. Its previous closing price was recorded at $9.11.
For the current Fiscal Quarter, 8 analysts have given an Average earnings estimate of $-0.27 per share. According to the Analysts, the Low Estimate Earnings of the current Quarter is $-0.31 while High Estimate is $-0.15. The Previous Year EPS of this Quarter is $0.02.
According to 6 analysts, an Average Revenue Estimate of the current Fiscal quarter is $29.94M. According to them, the Low Revenue estimate is $27.36M and High Revenue estimate is $33.00M.
The Company currently has High Price Target of $20. The Low and Mean Price Targets are $6.75 and $14.54 respectively. These price targets are set after consensus analysis of 7 brokers.
When having look at Recommendation Trends of the analysts polled at Thomson First call, for the Current month, 3 analysts have given this stock as Strong Buy where 4 issued Buy, 0 analysts think that it’s a Hold, 0 told Underperform and1 assigned Sell rating.